Alcon Laboratories (Australia) Pty Ltd

Manufacturer / marketing-authorisation holder

Alcon Laboratories (Australia) Pty Ltd — 17 products across 1 markets, 14 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.

Alcon Laboratories (Australia) Pty Ltd — 17 productos en 1 mercados, 14 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.

Alcon Laboratories (Australia) Pty Ltd —— 共 17 个产品,覆盖 1 个市场、14 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。

17 products · 1 markets · 14 brand names

17 productos · 1 mercados · 14 marcas

17 个产品 · 1 个市场 · 14 个品牌名

Products by country

AU (17 records)

Source: compliance.health.gov.au

BrandActive ingredient(s)Form
ALCAINE proxymetacaine hydrochloride 0.5% eye drops bottleProxymetacaine Hydrochlorideliquid
CYCLOGYL cyclopentolate hydrochloride 1% eye drops bottleCyclopentolateliquid
FLUORESCITE fluorescein 10% 500mg/5mL (as sodium) injection vial荧光素injection
MIOSTAT carbachol 0.15mg/1.5mL intraocular injection卡巴胆碱injection
MYDRIACYL tropicamide 0.5% eye drops bottle托吡卡胺liquid
MYDRIACYL tropicamide 1% eye drops bottle托吡卡胺liquid
NAPHCON FORTE naphazoline hydrochloride 1mg/mL eye drops bottle盐酸萘甲唑啉liquid
NAPHCON-A eye drops bottle盐酸萘甲唑啉 + Pheniramineliquid
Poly ViscParaffintopical
Poly ViscParaffintopical
Poly-Tears右旋糖酐70 + 羟丙甲纤维素liquid
SYSTANE RED EYES naphazoline hydrochloride 1 mg/mL eye drops bottle盐酸萘甲唑啉liquid
SystanePolyethylene Glycol 400 + Propylene Glycolliquid
SystanePolyethylene Glycol 400 + Propylene Glycolliquid
SystanePolyethylene Glycol 400 + Propylene Glycolliquid
Systane BalancePropylene Glycolliquid
Tears Naturale右旋糖酐70 + 羟丙甲纤维素liquid
Source & licence: product rows link to the regulator record (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA); facts only — see the licence register.